Vera Therapeutics Inc (VERA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Marshall W. Fordyce
Employees:
30
170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080
650-770-0077

Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for immunoglobulin A nephropathy.

Data derived from most recent annual or quarterly report
Market Cap 206.603 Million Shares Outstanding27.658 Million Avg 30-day Volume 518.351 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.91
Price to Revenue0.0 Debt to Equity0.047 EBITDA-74.129 Million
Price to Book Value5.486 Operating Margin0.0 Enterprise Value470.394 Million
Current Ratio7.851 EPS Growth1.056 Quick Ratio7.187
1 Yr BETA 0.9292 52-week High/Low 24.94 / 5.2 Profit Margin0.0
Operating Cash Flow Growth-18.409 Altman Z-Score10.7796 Free Cash Flow to Firm -49.705 Million

Are you looking for this stock instead?

View recent insider trading info

Funds Holding VERA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VERA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

4.3 Million total shares from 20 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SEIDENBERG BETH C

  • Director
1,919,621 2023-03-17 10

CURLEY JOANNE CHIEF DEVELOPMENT OFFICER

  • Officer
0 2023-02-15 18

LIN CELIA CHIEF MEDICAL OFFICER

  • Officer
0 2023-02-15 2

FORDYCE MARSHALL PRESIDENT AND CEO

  • Officer
  • Director
0 2023-02-15 10

YOUNG JOSEPH R SVP, FINANCE, CHIEF ACCT OFFCR

  • Officer
0 2023-02-15 4

GRANT SEAN CHIEF FINANCIAL OFFICER

  • Officer
0 2023-02-15 4

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.P.

HEALY JAMES

KATABI MAHA

SOFINNOVA MANAGEMENT X-A, L.L.C.

  • Director
  • 10% Owner
3,467,156 2023-02-06 1

ENRIGHT PATRICK G

  • Director
  • 10% Owner
5,144,212 2023-02-06 2

LONGITUDE CAPITAL PARTNERS IV, LLC

LONGITUDE PRIME PARTNERS, LLC

LONGITUDE PRIME FUND, L.P.

LONGITUDE VENTURE PARTNERS IV, L.P.

TAMMENOMS BAKKER JULIET

  • 10% Owner
5,144,212 2023-02-06 1

LONGITUDE PRIME PARTNERS, LLC

LONGITUDE PRIME FUND, L.P.

  • 10% Owner
1,714,285 2023-02-06 1

CARLYLE GROUP INC.

ABINGWORTH LLP

ABINGWORTH BIOVENTURES 8 LP

CARLYLE HOLDINGS I GP INC.

CARLYLE HOLDINGS I GP SUB L.L.C.

CARLYLE HOLDINGS I L.P.

CG SUBSIDIARY HOLDINGS L.L.C.

TC GROUP, LLC

CARLYLE INVESTMENT MANAGEMENT LLC

CARLYLE GENESIS UK LLC

  • 10% Owner
2,960,231 2022-08-17 2

CARLYLE GROUP INC.

CARLYLE HOLDINGS I GP INC.

CARLYLE HOLDINGS I GP SUB L.L.C.

CARLYLE HOLDINGS I L.P.

CG SUBSIDIARY HOLDINGS L.L.C.

TC GROUP, LLC

CARLYLE INVESTMENT MANAGEMENT LLC

CARLYLE GENESIS UK LLC

  • 10% Owner
2,960,231 2022-08-01 2

MORRISSEY MICHAEL

  • Director
40,000 2022-05-24 2

MORRISON SCOTT W

  • Director
9,925 2022-05-24 1

KATABI MAHA

  • Director
  • 10% Owner
9,925 2022-05-24 1

CHENG ANDREW

  • Director
9,925 2022-05-24 1

HALL KIMBALL

  • Director
9,925 2022-05-24 1

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

KATABI MAHA

  • Director
  • 10% Owner
3,181,442 2022-02-10 1

LONGITUDE CAPITAL PARTNERS IV, LLC

LONGITUDE VENTURE PARTNERS IV, L.P.

TAMMENOMS BAKKER JULIET

  • 10% Owner
3,429,927 2022-02-10 1

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

POWELL MICHAEL

  • 10% Owner
2,914,776 2021-05-18 0

EMSTER KURT VON

  • Director
2,978,059 2021-05-17 0

ABINGWORTH LLP

  • 10% Owner
0 2021-05-13 0

COLLINS SETH

  • Director
90,000 2011-11-08 0

MAZZULLO ANTHONY C CEO & PRESIDENT

  • Officer
210,820 2011-09-20 0

MOYLAN ANDREW W

  • Director
17,000 2008-06-09 0

HOLLY MICHAEL R

  • Director
10,000 2007-01-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SEIDENBERG BETH C - Director see footnote

2023-03-21 16:40:40 -0400 2023-03-20 P 15,252 $7.21 a 1,919,621 indirect 1.0825 1.0825 2 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-03-21 16:40:40 -0400 2023-03-17 P 74,045 $7.12 a 1,904,369 indirect 1.0825 1.0825 2 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-03-17 16:10:04 -0400 2023-03-16 P 60,097 $7.09 a 1,830,324 indirect -0.6684 0.0 1 -0.6684 2

SEIDENBERG BETH C - Director see footnote

2023-03-17 16:10:04 -0400 2023-03-15 P 32,844 $7.12 a 1,770,227 indirect -0.6684 0.0 1 -0.6684 2

SEIDENBERG BETH C - Director see footnote

2023-03-14 16:05:23 -0400 2023-03-10 P 48,003 $7.16 a 1,737,383 indirect 1.8233 3.6466 4.9088 4 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-03-07 16:07:06 -0500 2023-03-03 P 1,000 $7.25 a 1,689,380 indirect -4.5735 -11.8665 0.0 1 -11.8665 6

SEIDENBERG BETH C - Director see footnote

2023-03-03 16:07:27 -0500 2023-03-02 P 23,378 $7.24 a 1,688,380 indirect -0.9569 -11.9617 0.0 1 -11.9617 6

SEIDENBERG BETH C - Director see footnote

2023-03-03 16:07:27 -0500 2023-03-01 P 100 $7.25 a 1,665,002 indirect -0.9569 -11.9617 0.0 1 -11.9617 6

SEIDENBERG BETH C - Director see footnote

2023-02-27 16:07:12 -0500 2023-02-23 P 200 $7.24 a 1,664,902 indirect -0.4038 11.4401 12.5168 5 -2.5572 3

FORDYCE MARSHALL - Director - Officer PRESIDENT AND CEO

2023-02-17 16:05:22 -0500 2023-02-15 A 450,000 a 450,000 direct

LIN CELIA - Officer CHIEF MEDICAL OFFICER

2023-02-17 16:08:19 -0500 2023-02-15 A 100,000 a 100,000 direct

YOUNG JOSEPH R - Officer SVP, FINANCE, CHIEF ACCT OFFCR

2023-02-17 16:14:40 -0500 2023-02-15 A 90,000 a 90,000 direct

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER

2023-02-17 16:10:21 -0500 2023-02-15 A 200,000 a 200,000 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2023-02-17 16:12:44 -0500 2023-02-15 A 150,000 a 150,000 direct

SEIDENBERG BETH C - Director see footnote

2023-02-15 18:32:44 -0500 2023-02-13 P 10,072 $7.20 a 1,664,702 indirect 4.6192 -6.6167 4.6192 2 -6.6167 6

SEIDENBERG BETH C - Director see footnote

2023-02-13 16:04:54 -0500 2023-02-09 P 400 $7.25 a 1,654,630 indirect 0.5109 0.1277 7.0243 4 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-02-09 16:36:02 -0500 2023-02-08 P 45,357 $7.22 a 1,654,230 indirect 0.4016 12.1821 12.1821 6 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-02-09 16:36:02 -0500 2023-02-07 P 87,956 $7.08 a 1,608,873 indirect 0.4016 12.1821 12.1821 6 0.0 1

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER

2023-02-17 16:17:30 -0500 2023-02-06 P 14,285 $7.00 a 49,933 direct -2.4876 -7.5871 0.0 1 -7.5871 6

YOUNG JOSEPH R - Officer SVP, FINANCE, CHIEF ACCT OFFCR

2023-02-17 16:19:19 -0500 2023-02-06 P 5,714 $7.00 a 22,679 direct -2.4876 -7.5871 0.0 1 -7.5871 6

SOFINNOVA VENTURE PARTNERS X, L.P. - > 10% Owner

SOFINNOVA MANAGEMENT X, L.P. - > 10% Owner

HEALY JAMES - > 10% Owner

KATABI MAHA - Director - > 10% Owner

SOFINNOVA MANAGEMENT X-A, L.L.C. - > 10% Owner

2023-02-08 18:29:55 -0500 2023-02-06 P 285,714 $7.00 a 3,467,156 direct 2.6099 10.0275 10.0275 6 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-02-09 16:36:02 -0500 2023-02-06 P 131,602 $7.03 a 1,520,917 indirect 0.4016 12.1821 12.1821 6 0.0 1

LONGITUDE CAPITAL PARTNERS IV, LLC - > 10% Owner see footnote

LONGITUDE PRIME PARTNERS, LLC - > 10% Owner see footnote

LONGITUDE PRIME FUND, L.P. - > 10% Owner see footnote

LONGITUDE VENTURE PARTNERS IV, L.P. - > 10% Owner see footnote

TAMMENOMS BAKKER JULIET - > 10% Owner see footnote

2023-02-08 19:40:20 -0500 2023-02-06 P 1,714,285 $7.00 a 1,714,285 indirect 2.6099 10.0275 10.0275 6 0.0 1

ENRIGHT PATRICK G - Director - > 10% Owner see footnote

2023-02-08 19:32:52 -0500 2023-02-06 P 1,714,285 $7.00 a 1,714,285 indirect 2.6099 10.0275 10.0275 6 0.0 1

SEIDENBERG BETH C - Director see footnote

2023-02-09 16:36:02 -0500 2023-02-03 P 46,163 $7.24 a 1,389,315 indirect 0.4016 12.1821 12.1821 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VERA THERAPEUTICS INC VERA 2023-03-24 22:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 21:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 21:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 20:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 20:15:04 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 19:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 19:15:04 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 18:45:04 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 18:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 17:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 17:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 16:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 16:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 15:45:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 15:15:03 UTC 0.8681 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 14:45:03 UTC 0.6181 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 14:15:03 UTC 0.6181 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 13:45:03 UTC 0.6181 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 13:15:04 UTC 0.6181 3.9519 200000
VERA THERAPEUTICS INC VERA 2023-03-24 12:45:03 UTC 0.6181 3.9519 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments